Clinical application of ghrelin for chronic respiratory diseases

Methods in Enzymology

Volumn 514, Issue , 2012, Pages 399-407

  Matsumoto, Nobuhiro ^a   Nakazato, Masamitsu ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

cachexia; chronic lower respiratory infection; chronic obstructive pulmonary disease; chronic respiratory disease; clinical trial; COPD; exercise tolerance

Indexed keywords

CYTOKINE; FREE RADICAL; GHRELIN; GROWTH HORMONE; HORMONE DERIVATIVE; OCTANOIC ACID; PLACEBO; PREALBUMIN; RETINOL BINDING PROTEIN; TRANSFERRIN; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ACYLATION; ANTIINFLAMMATORY ACTIVITY; APPETITE; ARTICLE; BACKACHE; BODY WEIGHT; BREATHING MUSCLE; BRONCHIECTASIS; CACHEXIA; CARDIOPULMONARY EXERCISE TEST; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; CLINICAL EFFECTIVENESS; DIARRHEA; DIETARY INTAKE; DIFFUSION; DIZZINESS; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; DRUG SYNTHESIS; DRUG TOLERABILITY; ENERGY METABOLISM; EVENING DOSAGE; EXERCISE; EXERCISE TOLERANCE; FEVER; FOOD INTAKE; GLUCOSE URINE LEVEL; HEADACHE; HUMAN; HUNGER; HYPERHIDROSIS; INSOMNIA; LEUKOCYTOSIS; LOWER RESPIRATORY TRACT INFECTION; LUNG TUBERCULOSIS; METABOLIC REGULATION; MORNING DOSAGE; MUSCLE STRENGTH; NAUSEA; NUTRITIONAL STATUS; OUTCOME ASSESSMENT; PERISTALSIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN METABOLISM; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIDE EFFECT; SOMNOLENCE; SORE THROAT; SUFFUSION; SWEATING; WEIGHT REDUCTION;

EID: 84866250065     PISSN: 00766879     EISSN: 15577988     Source Type: Book Series    
DOI: 10.1016/B978-0-12-381272-8.00025-8     Document Type: Chapter

References (35)

1. S. Adachi Effects of ghrelin administration after total gastrectomy: a prospective, randomized, placebo-controlled phase II study Gastroenterology 138 2010 1312 1320
2. A.G. Agustí Skeletal muscle apoptosis and weight loss in chronic obstructive pulmonary disease Am. J. Respir. Crit. Care Med. 166 2002 485 489
3. T. Akamizu Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects Eur. J. Endocrinol. 150 2004 447 455
4. T. Akamizu Repeated administration of ghrelin to patients with functional dyspepsia: its effects on food intake and appetite Eur. J. Endocrinol. 158 2008 491 498
5. T. Akamizu Effects of ghrelin treatment on patients undergoing total hip replacement for osteoarthritis: different outcomes from studies in patients with cardiac and pulmonary cachexia J. Am. Geriatr. Soc. 56 2008 2363 2365
6. S.D. Anker Wasting as independent risk factor for mortality in chronic heart failure Lancet 349 1997 1050 1053
7. J. Ashitani Effect of octanoic acid-rich formula on plasma ghrelin levels in cachectic patients with chronic respiratory disease Nutr. J. 8 2009 25
8. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories ATS statement: guidelines for the six-minute walk test Am. J. Respir. Crit. Care Med. 166 2002 111 117
9. V.D. Dixit Ghrelin inhibits leptin- and activation-induced proinflammatory cytokine expression by human monocytes and T cells J. Clin. Invest. 114 2004 57 66
10. M. Enomoto Cardiovascular and hormonal effects of subcutaneous administration of ghrelin, a novel growth hormone-releasing peptide, in healthy humans Clin. Sci. (Lond.) 105 2003 431 435
11. J. Gertner, and B. Levinson SUN11031 (synthetic human Ghrelin) improves lean body mass and function in advanced COPD cachexia in a placebo controlled trial Growth Horm. IGF Res. 20 2010 S1 S38
12. R. Gosselink Exercise training in COPD patients: the basic questions Eur. Respir. J. 10 1997 2884 2891
13. Y. Hataya A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans J. Clin. Endocrinol. Metab. 86 2001 4552
14. M. Hotta Ghrelin increases hunger and food intake in patients with restricting-type anorexia nervosa: a pilot study Endocr. J. 56 2009 1119 1128
15. P.W. Jones A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire Am. Rev. Respir. Dis. 145 1992 1321 1327
16. T. Kodama Ghrelin treatment suppresses neutrophil-dominant inflammation in airways of patients with chronic respiratory infection Pulm. Pharmacol. Ther. 21 2008 774 779
17. M. Kojima Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660
18. W.G. Li Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells Circulation 109 2004 2221 2226
19. K. Miki Ghrelin treatment of cachectic patients with chronic obstructive pulmonary disease: A multicenter, randomized, double-blind, placebo-controlled trial PLoS One 7 2012 e35708
20. N. Nagaya Hemodynamic and hormonal effects of human ghrelin in healthy volunteers Am. J. Physiol. Regul. Integr. Comp. Physiol. 280 2001 R1483 1487
21. N. Nagaya Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure J. Clin. Endocrinol. Metab. 86 2001 5854 5859
22. N. Nagaya Effects of ghrelin administration on left ventricular function, exercise capacity, and muscle wasting in patients with chronic heart failure Circulation 110 2004 3674 3679
23. N. Nagaya Treatment of cachexia with ghrelin in patients with COPD Chest 128 2005 1187 1193
24. R.A. Pauwels Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary Am. J. Respir. Crit. Care Med. 163 2001 1256 1276
25. A.M. Schols Pulmonary cachexia Int. J. Cardiol. 85 2002 101 110
26. A.M. Schols Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease Thorax 51 1996 819 824
27. S. Solway A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain Chest 119 2001 256 270
28. K. Takaya Ghrelin strongly stimulates growth hormone release in humans J. Clin. Endocrinol. Metab. 85 2000 4908 4911
29. R. Takeno Intravenous administration of ghrelin stimulates growth hormone secretion in vagotomized patients as well as normal subjects Eur. J. Endocrinol. 151 2004 447 450
30. J.E. Ware, and C.D. Sherbourne The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection Med. Care 30 1992 473 483
31. K. Wasserman Principles of Exercise Testing and Interpretation third ed 1999 Lippincott, Williams & Wilkins Philadelphia
32. I.M. Weisman, and R.J. Zeballos An integrated approach to the interpretation of cardiopulmonary exercise testing Clin. Chest Med. 15 1994 421 445
33. D.O. Wilson Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial Am. Rev. Respir. Dis. 139 1989 1435 1438
34. K. Yamamoto Randomized phase II study of clinical effects of ghrelin after esophagectomy with gastric tube reconstruction Surgery 148 2010 31 38
35. M. Yamato Exogenous administration of octanoic acid accelerates octanoylated ghrelin production in the proventriculus of neonatal chicks Biochem. Biophys. Res. Commun. 333 2005 583 589